Xeris Pharmaceuticals | XERS - 债务



金融业
股票价格
USD
资产
USD 392.01M
现金及等价物
USD 111.75M
销售成本
USD 13.66M
流动资产
USD 251.68M
流动负债
USD 118.59M
债务
USD 257.65M
EBIT
USD 16.77M
EBITDA
USD 25.09M
员工
377
EPS每股收益
USD 0.01
股本和储备
USD 13.01M
销售毛利
USD 72.15M
债务利息支出
USD 7.15M
利息收入
USD 1.16M
贷款资金
USD 221.22M
市值
USD 976.2M
净收入
USD 11.08M
营业费用
USD 69.03M
营业利润
USD 16.77M
普通股股本
USD 166.22M
PE价格收益
2.45K
税前利润
USD 11.08M
销售收入
USD 83.13M
销售和管理费用
USD 42.64M
股票
USD 74.23M
贸易债权人
USD 11.47M
应收帐款人
USD 51.05M


债务 更改 日
Celltrion KRW 161.31B 9.78B 2025-12
Cspc Pharmaceutical CNY 495M 12.33M 2025-06
Deva Holding AS TRY 5.3B 871.93M 2023-09
Dianthus Therapeutics USD 1.28M 45K 2025-09
Divis Laboratories Ltd INR 40M 40M 2025-03
Eli Lilly USD 42.5B 3.6M 2025-12
Kangmei Pharma CNY 173.71M 42.08M 2026-03
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Malin Corporation EUR 100K 0 2023-12
Medical Developments International AUD 1.99M 152K 2025-06
Nektar Therapeutics USD 0 0 2022-06
Neuren Pharmaceuticals AUD 0 0 2024-12
Ovoca Bio EUR 0 0 2021-06
Pacira USD 367.66M 4.53M 2026-03
Perrigo USD 3.64B 4.5M 2025-12
Pharma Mar EUR 47.54M 1.88M 2026-03
Qiagen NV USD 1.81B 314.82M 2025-12
Sartorius EUR 4.28B 372.9M 2025-12
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Supernus Pharmaceuticals USD 40.98M 1.23M 2025-12
Tilray USD 640.95M 35.17M 2022-06
Zz Pientze Pharmaceu CNY 1.07B 2.82M 2026-03